Taro Pharmaceutical ends licensing agreement with NovaBiotics over Novexatin failure

Taro Pharmaceutical Industries has terminated its licensing agreement with Scottish biotech company NovaBiotics concerning the Novexatin drug after disappointing clinical trial results. The decision follows ... Read More